Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$43.8 - $56.99 $17 Million - $22.1 Million
387,384 New
387,384 $21 Billion
Q4 2022

Feb 14, 2023

BUY
$44.07 - $54.45 $17.1 Million - $21.2 Million
388,766 New
388,766 $20.6 Million
Q3 2022

Nov 14, 2022

BUY
$42.7 - $59.99 $220,801 - $310,208
5,171 Added 1.35%
388,559 $18.1 Million
Q2 2022

Aug 15, 2022

SELL
$43.0 - $65.64 $91,160 - $139,156
-2,120 Reduced 0.55%
383,388 $21.9 Million
Q1 2022

May 11, 2022

BUY
$38.74 - $62.09 $736,021 - $1.18 Million
18,999 Added 5.18%
385,508 $23.6 Million
Q4 2021

Feb 11, 2022

BUY
$35.2 - $53.42 $746,873 - $1.13 Million
21,218 Added 6.14%
366,509 $19.2 Million
Q3 2021

Nov 12, 2021

BUY
$28.72 - $42.49 $389,069 - $575,612
13,547 Added 4.08%
345,291 $12.9 Million
Q2 2021

Aug 11, 2021

BUY
$29.3 - $44.5 $784,888 - $1.19 Million
26,788 Added 8.78%
331,744 $13.5 Million
Q1 2021

May 13, 2021

BUY
$30.8 - $39.51 $389,435 - $499,564
12,644 Added 4.33%
304,956 $10.3 Million
Q4 2020

Feb 09, 2021

SELL
$23.34 - $32.22 $447,987 - $618,430
-19,194 Reduced 6.16%
292,312 $9.3 Million
Q3 2020

Nov 12, 2020

BUY
$17.61 - $31.86 $1.08 Million - $1.95 Million
61,336 Added 24.52%
311,506 $7.99 Million
Q2 2020

Aug 12, 2020

BUY
$14.35 - $26.64 $260,352 - $483,329
18,143 Added 7.82%
250,170 $6.42 Million
Q1 2020

May 06, 2020

BUY
$12.31 - $33.12 $531,127 - $1.43 Million
43,146 Added 22.84%
232,027 $3.57 Million
Q4 2019

Feb 14, 2020

SELL
$7.26 - $38.49 $9,554 - $50,652
-1,316 Reduced 0.69%
188,881 $6.48 Million
Q3 2019

Nov 07, 2019

SELL
$7.47 - $14.03 $113,738 - $213,620
-15,226 Reduced 7.41%
190,197 $1.42 Million
Q2 2019

Aug 12, 2019

SELL
$10.65 - $14.29 $101,899 - $136,726
-9,568 Reduced 4.45%
205,423 $2.67 Million
Q1 2019

May 14, 2019

BUY
$10.9 - $14.09 $53,747 - $69,477
4,931 Added 2.35%
214,991 $2.62 Million
Q4 2018

Feb 11, 2019

BUY
$10.36 - $20.96 $26,065 - $52,735
2,516 Added 1.21%
210,060 $2.39 Million
Q3 2018

Nov 09, 2018

BUY
$17.77 - $22.9 $15,015 - $19,350
845 Added 0.41%
207,544 $0
Q2 2018

Aug 06, 2018

SELL
$17.33 - $23.4 $35,647 - $48,133
-2,057 Reduced 0.99%
206,699 $3.65 Million
Q1 2018

May 15, 2018

SELL
$15.16 - $25.49 $95,053 - $159,822
-6,270 Reduced 2.92%
208,756 $4.39 Million
Q4 2017

Feb 09, 2018

BUY
$14.27 - $16.79 $3.07 Million - $3.61 Million
215,026
215,026 $3.11 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.